Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Paired with SOLSpotitEarly, a biotech startup working to transform cancer screening, just released a new study, pointing to the successful results of using both artificial intelligence and canines to detect cancer early in breath samples. The researchers call this a “bio-AI hybrid” cancer screening approach. By using AI to assist cancer-sniffing dogs — which have long been utilized by various laboratories to detect disease — cancers including breast, lung, prostate, and colorectal cancers were able to be detected with high rates of success. The research, dubbed “The Rainbow Study” has just been published in Nature and marks the largest clinical trial to date for cancer detection using both AI and trained canines.
